Sangamo Therapeutics Inc.

(SGMO) Trade

By |

Profile

Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.

Contact Information

Website: www.sangamo.com
Main Phone: +1 510 970-6000
Address: 501 Canal Boulevard
State: CA
City / Town: Richmond
Country: USA
Postal Code: 94804

Issuer Information

Exchange: NGS
CEO: Alexander Macrae
Employees: 182
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 15.10 $ -0.05 (-0.33%)
Last Price 15.10 Change $ -0.05 Change % -0.33 Tick N/A
Bid 14.00 Bid Size 200.00 Ask 16.00 Ask Size 500.00
Open 15.20 High 15.30 Low 14.70 Prev Close 15.15
Last Trade Volume 983,014 52 Wk Hi 27.50 52 Wk Low 8.00
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 101,494,606.00 EPS (TTM) -0.70 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 27 94
Number of Buys 17 55
Number of Sells 10 39
Net Activity 20285 49487
Last 10 Buys Shares
H. Ward Wolff 1,000
Edward O. Lanphier 1,000
Last 10 Sell Shares
Edward R. Conner 1,000
Kathy Yi 1,000
Edward R. Conner 1,000
Kathy Yi 1,000
Curt A. Herberts 1,000
Edward R. Conner 1,000
Steven J. Mento 1,000
Steven J. Mento 1,000
Curt A. Herberts 1,000
Kathy Yi 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 39 39 39 39
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 28.2 28.2 28.2 28.2
Standard Deviation 11.56 11.56 11.56 11.56
Date of Most Recent Estimate 05/21/18 05/21/18 05/21/18 05/21/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.29